Long term safety and efficacy of perinatal probiotic intervention: Evidence from a follow up study of four randomized, double blind, placebo controlled trials
Societies worldwide are faced with a progressive increase in immune mediated health problems such as allergic, autoimmune, and inflammatory diseases, as well as obesity. Perinatal administration of specific probiotic bacteria is an attractive approach in reducing the risk of these conditions, but long term efficacy and safety data are lacking. The aim here was to evaluate the clinical benefit and long term safety of specific probiotics administered during the perinatal period.
Pediatric allergy and immunology official publication of the European Society of Pediatric Allergy and Immunology